25 active shortage notices across 9 countries · 1 anticipated.
Last updated 2 Aug 2026 · sourced from official medicines regulators
| Country | Severity | Notices | Since | Est. resolution | Source |
|---|---|---|---|---|---|
| Colombia | high | 1 | 1 May 2025 | — | INVIMA |
| United States | high | 1 | 22 Mar 2023 | — | FDA MedWatch |
| Peru | medium | 6 | 21 Feb 2020 | 1 Jun 2024 | DIGEMID |
| Italy | medium | 4 | 10 Sept 2025 | 31 Dec 2026 | AIFA |
| Canada | medium | 4 | 12 Oct 2018 | 3 Jul 2026 | HC |
| Germany | medium | 4 | 14 Aug 2025 | 27 May 2026 | BfArM |
| Belgium | medium | 3 | 8 Oct 2025 | 31 Aug 2026 | FAMHP |
| Bosnia and Herzegovina | medium | 1 | 20 Feb 2026 | 31 Dec 2026 | ALMBIH |
| Croatia | medium | 1 | 5 May 2022 | — | HALMED |
Yes. As of the latest regulator updates, Alprazolam has 25 active shortage notices across 9 countries (Colombia, United States, Peru, Italy, Canada, Germany and more). Status is refreshed daily from official regulatory sources.
Regulators attribute the current Alprazolam shortages to manufacturing problems, unexpected increases in demand, causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
Regulator-estimated resolution dates currently range from 1 Dec 2020 to 31 Dec 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Buspirone Hydrochloride · Chlordiazepoxide Hydrochloride · Diazepam Tablets 2 Mg · Lorazepam · Clobazam · Diazepam(2 Mg)
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.